Skip to main content
. 2021 Sep 22;26(11):925–e1918. doi: 10.1002/onco.13911
Title Response
Number of Patients Screened 21
Number of Patients Enrolled 6
Number of Patients Evaluable for Toxicity 6
Number of Patients Evaluated for Efficacy 2
Evaluation Method RECIST 1.1
Response Assessment CR n = 0 (0%)
Response Assessment PR n = 0 (0%)
Response Assessment SD n = 0 (0%)
Response Assessment PD n = 2
Response Assessment OTHER n = 0 (0%)